Skip to Main Content

Paper Details

RT-PCR/MALDI-TOF Diagnostic Target Performance Reflects Circulating SARS-CoV-2 Variant Diversity in New York City.
J Mol Diagn
2
2022
28095A, Alpha, Delta, N, N and, N gene, N2, N2 probe, N3, N3 forward PBS, ORF1ab genes, PBS, PBSs, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 Panel, primer/probe-binding sites, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Ana S Gonzalez-ReicheIcahn School of Medicine at Mount Sinai
Robert SebraIcahn School of Medicine at Mount Sinai, New York Icahn Institute for Data Science and Genomic Technology, New York Black Family Stem Cell Institute
Robert SebraIcahn School of Medicine at Mount Sinai, New York Icahn Institute for Data Science and Genomic Technology, New York Black Family Stem Cell Institute
Viviana SimonIcahn School of Medicine at Mount Sinai, New York The Global Health and Emerging Pathogens Institute
Harm van BakelIcahn School of Medicine at Mount Sinai, New York Icahn Institute for Data Science and Genomic Technology
Harm van BakelIcahn School of Medicine at Mount Sinai, New York Icahn Institute for Data Science and Genomic Technology
Emilia Mia SordilloIcahn School of Medicine at Mount Sinai
  • 1 - 7

Datasets

Release 1.2